Donanemab (Anti-Amyloid Beta)
Product Specifications
CAS Number
1931944-80-7
Synonyms
LY3002813
Target
Beta Amyloid
Applications
Neuronal Signaling
Additionnal Information
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research. MW : 145.36 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880348-100 1x 100 µL
Histiocytoma Marker (D11), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942375-100 1x 100 µL
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/2375), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC743295-100 1x 100 µL
Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3295), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details